Host resistance against intracellular pathogens requires a rapid IFN- mediated immune response. We reveal that T-bet-dependent production of IFN- is essential for the maintenance of inflammatory DCs at the site of infection with a common protozoan parasite, Toxoplasma gondii. A detailed analysis of the cellular sources for T-bet-dependent IFN- identified that ILC1s, but not NK or T H 1 cells, were involved in the regulation of inflammatory DCs via IFN-.Mechanistically, we established that T-bet dependent ILC1-derived IFN- is critical for the induction of IRF8, an essential transcription factor for cDC1s. Failure to upregulate IRF8 in DCs resulted in acute susceptibility to T. gondii infection. Our data identifies that ILC1-derived IFN- is indispensable for host resistance against intracellular infection via maintaining IRF8+ inflammatory DCs at the site of infection. Author SummaryMounting a robust type I innate immune response is essential for resistance against numerous intracellular pathogens. The type I immune response is characterized by the production of IFN-, a central cytokine required for multiple non-redundant effector functions against bacterial, viral, and parasitic pathogens. Previous work has shown that group 1 innate lymphocyte cells (ILC1s) together with NK and CD4+ T cells play an indispensable IFN- mediated protective role against Toxoplasma gondii infection; yet, the pathway of how IFN- produced by ILC1s defend against T. gondii remains unknown. In this work we identified that early production of IFN- by ILC1 is essential for maintaining dendritic cells (DCs) during infection. Mechanistically, we reveal that ILC1-derived IFN- is indispensable for inducing the transcription factor IRF8 that is critical for sustaining inflammatory DCs. Finally, we demonstrate that IRF8+ DCs are critical for parasite elimination.
Cytokines are key players in inflammation, a process associated with tumour initiation, angiogenesis and metastasis. However, the interplay between inflammation and other cell types in the tumour microenvironment is not well understood. Here we show that the IL6-related proinflammatory cytokine Oncostatin M (OSM) is a central node for multicellular interactions. Myeloid-derived OSM reprogrammes cancer-associated fibroblasts (CAFs) and cancer cells, promoting breast cancer progression. In addition, OSM induces, in both cell types, the secretion of inflammatory cytokines and chemokines, which in turn reinforce myeloid tumour infiltration. OSM is increased in cancer stroma and is associated with poor prognosis in multiple cancer types. Oncostatin M receptor (OSMR) deletion in stroma and in a multistage breast cancer mouse model delays tumour onset, tumour growth and reduces metastatic burden. Our results reveal an unprecedented tumour-promoting paracrine OSM:OSMR signalling crosstalk encompassing myeloid cells, CAFs and tumour cells, thus encouraging therapeutic strategies aimed at targeting this oncogenic axis in breast cancer.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.